Skip to main content
logo
BIOBIJOU Co.,Ltd. (KOSDAQ:489460)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,390
+440 (4.02%)
At close: Aug 11, 2026

BIOBIJOU Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
24,91928,49129,63317,130
Revenue Growth
-27.75%-3.85%72.99%-
Gross Profit
15,80915,87914,8198,259
Operating Income
4,7274,2279,2275,165
Net Income
5,3544,1527,1883,310
Earnings Per Share
362.62298.30630.00308.13
EPS Growth
-44.70%-52.65%104.46%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
27,36118,69711,49013,064
Total Debt
318.89373.542,38814,849
Net Cash (Debt)
27,04218,3249,102-1,785
Net Cash Growth
197.09%101.31%--
Net Cash Per Share
1831.361316.49797.76-166.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
4.69-2,771558.344,073
Capital Expenditures
-385.82-348.76-97.29-35.64
Free Cash Flow
-381.14-3,120461.054,038
Free Cash Flow Growth
---88.58%-

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
63.44%55.73%50.01%48.21%
Operating Margin
18.97%14.84%31.14%30.15%
Pretax Margin
26.50%17.55%30.30%24.68%
Profit Margin
21.49%14.57%24.26%19.32%
FCF Margin
-1.53%-10.95%1.56%23.57%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PE Ratio
31.4148.84--
PS Ratio
6.887.12--